OncoMatch/Clinical Trials/NCT07813377

Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)

Is NCT07813377 recruiting? Yes, currently enrolling (Oct 2026).

RecruitingFundacion Clinic per a la Recerca BiomédicaNCT07813377Data as of Oct 2026Location: Spain

The objective of our study is to investigate the clinical significance of thromboelastometric values in the development of thrombotic events and survival in patients with glial tumors, to reduce thromboembolic complications and optimize oncological treatment.

Check if I qualify

Eligibility summary

For patients with glial tumor.

This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.

Frequently asked questions

Is NCT07813377 currently recruiting?

Yes, this trial is currently recruiting patients.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify